These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 18161660)

  • 1. Urinary cell-free DNA as a potential tumor marker for bladder cancer.
    Chang HW; Tsui KH; Shen LC; Huang HW; Wang SN; Chang PL
    Int J Biol Markers; 2007; 22(4):287-94. PubMed ID: 18161660
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of cell-free DNA in urine as a marker for bladder cancer diagnosis.
    Zancan M; Galdi F; Di Tonno F; Mazzariol C; Orlando C; Malentacchi F; Agostini M; Maran M; Del Bianco P; Fabricio AS; Murer B; Pianon C; Gion M
    Int J Biol Markers; 2009; 24(3):147-55. PubMed ID: 19787625
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urine cell-free DNA integrity as a marker for early bladder cancer diagnosis: preliminary data.
    Casadio V; Calistri D; Tebaldi M; Bravaccini S; Gunelli R; Martorana G; Bertaccini A; Serra L; Scarpi E; Amadori D; Silvestrini R; Zoli W
    Urol Oncol; 2013 Nov; 31(8):1744-50. PubMed ID: 23141783
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urine Cell-Free DNA Integrity Analysis for Early Detection of Prostate Cancer Patients.
    Salvi S; Gurioli G; Martignano F; Foca F; Gunelli R; Cicchetti G; De Giorgi U; Zoli W; Calistri D; Casadio V
    Dis Markers; 2015; 2015():574120. PubMed ID: 26412928
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urinary Cell-Free DNA Quantification as Non-Invasive Biomarker in Patients with Bladder Cancer.
    Brisuda A; Pazourkova E; Soukup V; Horinek A; Hrbáček J; Capoun O; Svobodova I; Pospisilova S; Korabecna M; Mares J; Hanuš T; Babjuk M
    Urol Int; 2016; 96(1):25-31. PubMed ID: 26338254
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urine cell-free DNA integrity as a marker for early prostate cancer diagnosis: a pilot study.
    Casadio V; Calistri D; Salvi S; Gunelli R; Carretta E; Amadori D; Silvestrini R; Zoli W
    Biomed Res Int; 2013; 2013():270457. PubMed ID: 23509700
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cell-Free DNA Integrity Analysis in Urine Samples.
    Casadio V; Salvi S; Martignano F; Gunelli R; Ravaioli S; Calistri D
    J Vis Exp; 2017 Jan; (119):. PubMed ID: 28117781
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deletion analysis of tumor and urinary DNA to detect bladder cancer: urine supernatant versus urine sediment.
    Szarvas T; Kovalszky I; Bedi K; Szendroi A; Majoros A; Riesz P; Füle T; László V; Kiss A; Romics I
    Oncol Rep; 2007 Aug; 18(2):405-9. PubMed ID: 17611663
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Value of urinary topoisomerase-IIA cell-free DNA for diagnosis of bladder cancer.
    Kim YH; Yan C; Lee IS; Piao XM; Byun YJ; Jeong P; Kim WT; Yun SJ; Kim WJ
    Investig Clin Urol; 2016 Mar; 57(2):106-12. PubMed ID: 26981592
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of bladder cancer in urine by a tumor suppressor gene hypermethylation panel.
    Dulaimi E; Uzzo RG; Greenberg RE; Al-Saleem T; Cairns P
    Clin Cancer Res; 2004 Mar; 10(6):1887-93. PubMed ID: 15041703
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection and Surveillance of Bladder Cancer Using Urine Tumor DNA.
    Dudley JC; Schroers-Martin J; Lazzareschi DV; Shi WY; Chen SB; Esfahani MS; Trivedi D; Chabon JJ; Chaudhuri AA; Stehr H; Liu CL; Lim H; Costa HA; Nabet BY; Sin MLY; Liao JC; Alizadeh AA; Diehn M
    Cancer Discov; 2019 Apr; 9(4):500-509. PubMed ID: 30578357
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification and validation of the methylated TWIST1 and NID2 genes through real-time methylation-specific polymerase chain reaction assays for the noninvasive detection of primary bladder cancer in urine samples.
    Renard I; Joniau S; van Cleynenbreugel B; Collette C; Naômé C; Vlassenbroeck I; Nicolas H; de Leval J; Straub J; Van Criekinge W; Hamida W; Hellel M; Thomas A; de Leval L; Bierau K; Waltregny D
    Eur Urol; 2010 Jul; 58(1):96-104. PubMed ID: 19674832
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitation of Aurora kinase A gene copy number in urine sediments and bladder cancer detection.
    Park HS; Park WS; Bondaruk J; Tanaka N; Katayama H; Lee S; Spiess PE; Steinberg JR; Wang Z; Katz RL; Dinney C; Elias KJ; Lotan Y; Naeem RC; Baggerly K; Sen S; Grossman HB; Czerniak B
    J Natl Cancer Inst; 2008 Oct; 100(19):1401-11. PubMed ID: 18812553
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microsatellite alterations in human bladder cancer: detection of tumor cells in urine sediment and tumor tissue.
    Berger AP; Parson W; Stenzl A; Steiner H; Bartsch G; Klocker H
    Eur Urol; 2002 May; 41(5):532-9. PubMed ID: 12074795
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genomic Alterations in Liquid Biopsies from Patients with Bladder Cancer.
    Birkenkamp-Demtröder K; Nordentoft I; Christensen E; Høyer S; Reinert T; Vang S; Borre M; Agerbæk M; Jensen JB; Ørntoft TF; Dyrskjøt L
    Eur Urol; 2016 Jul; 70(1):75-82. PubMed ID: 26803478
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analytical and clinical evaluation of a new urinary tumor marker: bladder tumor fibronectin in diagnosis and follow-up of bladder cancer.
    Mutlu N; Turkeri L; Emerk K
    Clin Chem Lab Med; 2003 Aug; 41(8):1069-74. PubMed ID: 12964816
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bladder cancer detection in urine using DNA methylation markers: a technical and prospective preclinical validation.
    Hentschel AE; Beijert IJ; Bosschieter J; Kauer PC; Vis AN; Lissenberg-Witte BI; van Moorselaar RJA; Steenbergen RDM; Nieuwenhuijzen JA
    Clin Epigenetics; 2022 Feb; 14(1):19. PubMed ID: 35123558
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A possible noninvasive method for the detection of bladder cancer in patients: microsatellite analysis of free DNA in urine and blood.
    Utting M; Werner W; Müller G; Schubert J; Junker K
    Ann N Y Acad Sci; 2001 Sep; 945():31-5. PubMed ID: 11708492
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel diagnostic tool for the detection of bladder cancer: Measurement of urinary high mobility group box-1.
    Benlier N; Solakhan M; Yıldırım Z; Kaya V; Yıldırım ÖA; Orhan N; Çiçek H; Yıldırım M
    Urol Oncol; 2020 Aug; 38(8):685.e11-685.e16. PubMed ID: 32312640
    [TBL] [Abstract][Full Text] [Related]  

  • 20. From Detection to Cure - Emerging Roles for Urinary Tumor DNA (utDNA) in Bladder Cancer.
    Linscott JA; Miyagi H; Murthy PB; Yao S; Grass GD; Vosoughi A; Xu H; Wang X; Yu X; Yu A; Zemp L; Gilbert SM; Poch MA; Sexton WJ; Spiess PE; Li R
    Curr Oncol Rep; 2024 Aug; 26(8):945-958. PubMed ID: 38837106
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.